|
|
||||||||
1 From the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; and 2 Department of Ophthalmology, Nagoya City University Medical School, Nagoya, Japan.
PURPOSE. The activity of protein kinase C (PKC), preferentially ß isoform of PKC, has been shown to be elevated in the diabetic retina. Recently, LY333531, a specific inhibitor of PKC-ß, has been reported to improve the decrease of retinal blood flow in early diabetes. Increased leukocyte entrapment has been suggested to be involved in blood flow disturbances in the early diabetic retina. This study was designed quantitatively to evaluate leukocyte entrapment in the retinal microcirculation of diabetic rats and the effect of LY333531 on leukocyte entrapment.
METHODS. Diabetes was induced in male Long-Evans rats by intraperitoneal injection of streptozotocin (60 mg/kg). LY333531 (0.1, 1.0, or 10.0 mg/kg/d) was administered orally during a 4-week diabetic period. Leukocyte entrapment in the retinal microcirculation was quantitatively evaluated in vivo with acridine orange digital fluorography.
RESULTS. The number of leukocytes trapped in the retinal microcirculation of diabetic rats (mean ± SEM; 14.3 ± 1.3 cells/mm2) was significantly increased, compared with nondiabetic control rats (7.5 ± 0.3 cells/mm2; P < 0.0001). Oral administration of LY333531 significantly decreased the number of leukocytes trapped in the retinal microcirculation of diabetic rats (10.9 ± 0.6, 11.3 ± 0.7, and 10.4 ± 0.4 cells/mm2 with LY333531 0.1, 1.0, and 10.0 mg/kg/d, respectively; P < 0.05).
CONCLUSIONS. Treatment with LY333531 attenuated the increase of leukocyte entrapment in the retinal microcirculation during the period of early diabetes. This effect may contribute to the improvement of abnormal retinal blood flow in early diabetes with LY333531. LY333531 might have a therapeutic efficacy in preventing microcirculatory flow disturbances by trapped leukocytes in the early diabetic retina.
This article has been cited by other articles:
![]() |
Y. Kaji, T. Usui, S. Ishida, K. Yamashiro, T. C. B. Moore, J. Moore, Y. Yamamoto, H. Yamamoto, and A. P. Adamis Inhibition of Diabetic Leukostasis and Blood-Retinal Barrier Breakdown with a Soluble Form of a Receptor for Advanced Glycation End Products Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 858 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou, X.-L. Wang, K. G. Lamping, and H.-C. Lee Inhibition of Protein Kinase Cbeta Protects against Diabetes-Induced Impairment in Arachidonic Acid Dilation of Small Coronary Arteries J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Aiello, A. Clermont, V. Arora, M. D. Davis, M. J. Sheetz, and S.-E. Bursell Inhibition of PKC {beta} by Oral Administration of Ruboxistaurin Is Well Tolerated and Ameliorates Diabetes-Induced Retinal Hemodynamic Abnormalities in Patients Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Ben-Mahmud, G. E. Mann, A. Datti, A. Orlacchio, E. M. Kohner, and R. Chibber Tumor Necrosis Factor-{alpha} in Diabetic Plasma Increases the Activity of Core 2 GlcNAc-T and Adherence of Human Leukocytes to Retinal Endothelial Cells: Significance of Core 2 GlcNAc-T in Diabetic Retinopathy Diabetes, November 1, 2004; 53(11): 2968 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyahara, J. Kiryu, K. Yamashiro, K. Miyamoto, F. Hirose, H. Tamura, H. Katsuta, K. Nishijima, A. Tsujikawa, and Y. Honda Simvastatin Inhibits Leukocyte Accumulation and Vascular Permeability in the Retinas of Rats with Streptozotocin-Induced Diabetes Am. J. Pathol., May 1, 2004; 164(5): 1697 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Stanford The pathogenesis of diabetic retinopathy Br. J. Ophthalmol., April 1, 2004; 88(4): 444 - 445. [Full Text] [PDF] |
||||
![]() |
H. Luan, M. Leitges, R. R. Gupta, D. Pacheco, A. Seidner, J. Liggett, Y. Ito, R. Kowluru, and B. A. Berkowitz Effect of PKC{beta} on Retinal Oxygenation Response in Experimental Diabetes Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 937 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Donnelly, I Idris, and J V Forrester Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research Br. J. Ophthalmol., January 1, 2004; 88(1): 145 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yu, I. Morita, K. Shimokado, T. Iwai, and M. Yoshida Amlodipine Modulates THP-1 Cell Adhesion to Vascular Endothelium via Inhibition of Protein Kinase C Signal Transduction Hypertension, September 1, 2003; 42(3): 329 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chibber, B. M. Ben-Mahmud, G. E. Mann, J. J. Zhang, and E. M. Kohner Protein Kinase C {beta}2-Dependent Phosphorylation of Core 2 GlcNAc-T Promotes Leukocyte-Endothelial Cell Adhesion: A Mechanism Underlying Capillary Occlusion in Diabetic Retinopathy Diabetes, June 1, 2003; 52(6): 1519 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. He, C. Rask-Madsen, and G.L. King Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57. [Abstract] [PDF] |
||||
![]() |
M. J. Sheetz and G. L. King Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications JAMA, November 27, 2002; 288(20): 2579 - 2588. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Mori, T Hikichi, T Nagaoka, J Takahashi, N Kitaya, and A Yoshida Inhibitory effect of losartan, an AT1 angiotensin II receptor antagonist, on increased leucocyte entrapment in retinal microcirculation of diabetic rats Br. J. Ophthalmol., October 1, 2002; 86(10): 1172 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Booth, T. J. Stalker, A. M. Lefer, and R. Scalia Mechanisms of Amelioration of Glucose-Induced Endothelial Dysfunction Following Inhibition of Protein Kinase C In Vivo Diabetes, May 1, 2002; 51(5): 1556 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Rosenbaum Sugar Creates a Sticky Business: Round Up the Usual Suspects Am. J. Pathol., May 1, 2002; 160(5): 1547 - 1550. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |